z-logo
open-access-imgOpen Access
Monoclonal antibodies for the therapy of severe chronic rhinusinusitis with nasal polyps (CRSwNP) - first experiences in clinical routine
Author(s) -
P Nahrath,
M Cuevas,
Thomas Zahnert
Publication year - 2021
Publication title -
laryngo-rhino-otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0041-1728634
Subject(s) - medicine , omalizumab , nasal polyps , dupilumab , chronic rhinosinusitis , nose , quality of life (healthcare) , monoclonal antibody , disease , dermatology , paranasal sinuses , surgery , antibody , immunology , immunoglobulin e , atopic dermatitis , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom